Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2016
At a glance
- Drugs Trospium chloride (Primary)
- Indications Overactive bladder
- Focus Pharmacokinetics
- Acronyms SMART
- Sponsors Allergan
- 16 Sep 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 16 Sep 2010 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 14 Apr 2010 Results have been published as an abstract (62nd Annual Meeting of the American Academy of Neurology).